The results of protein expression including upregulation of SIRT1 and PGC1 and downregulation of FAS and FABP4 in liver tissue of the NDS group provided evidences to support amelioration of hepatic steatosis of APS1 might through the gut-liver axis. This evidence concerns the gene FAS and fatty liver disease.